Beneficial effects of weight loss on plasma apolipoproteins in postmenopausal women

Journal of Nutritional Biochemistry

Volumn 15, Issue 12, 2004, Pages 717-721

  Fernandez, Maria Luz ^a   Metghalchi, Shiva ^b   Vega López, Sonia ^a   Conde Knape, Karin ^a   Lohman, Timothy G ^c   Cordero Macintyre, Zaida R ^b  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b LOMA LINDA UNIVERSITY   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Apolipoprotein B; Apolipoprotein C III; Apolipoprotein E; Weight loss

Indexed keywords

APOLIPOPROTEIN; APOLIPOPROTEIN B; APOLIPOPROTEIN C2; APOLIPOPROTEIN E; APOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHENTERMINE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY FAT; BODY MASS; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; HORMONE SUBSTITUTION; HUMAN; LOW CALORY DIET; NORMAL HUMAN; POSTMENOPAUSE; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; WEIGHT REDUCTION;

ADULT; AGED; APOLIPOPROTEIN C-III; APOLIPOPROTEINS; APOLIPOPROTEINS B; APOLIPOPROTEINS C; APOLIPOPROTEINS E; APPETITE DEPRESSANTS; BODY MASS INDEX; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIET, REDUCING; ENERGY INTAKE; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; PHENTERMINE; POSTMENOPAUSE; TRIGLYCERIDES; WEIGHT LOSS;

EID: 10944248533     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2004.07.001     Document Type: Article

References (26)

1. A.M. Minino, E. Arias, K.D. Kochanek, S.L. Murphy, and B.L. Smith Deaths: final data for 2002 Natl. Vital. Stat. Rep. 50 2000 1 119
2. J. Stamler, D. Wentforth, and J.D. Neaton Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356, 222 primary screens of the Multiple Risk Factor Intervention Trial (MRFIT) JAMA 256 1986 2823 2828
3. W.P. Castelli Cholesterol and lipids in the risk of coronary heart disease. The Framingham Heart Study Can. J. Cardiol. 4 1988 5A 10A
4. C. Bonithon-Kopp, P.-Y. Scarabin, B. Darne, A. Malmejac, and L. Guize Menopause-related changes in lipoproteins and some other cardiovascular risk factors Int. J. Epidemiol. 19 1990 42 48
5. W.C. Willett, J.E. Manson, M.J. Stampfer, G.A. Colditz, B. Rosner, and F.E. Speizer Weight, weight change and coronary heart disease in women. Risk within the "normal" weight range JAMA 273 1995 461 465
6. D.K. Arnett, P.G. McGovern, D.R. Jacobs Jr, E. Shahar, S. Duval, and H. Blackburn Fifteen-year trends in cardiovascular risk factors (1980-1982 through 1995-1997). The Minnesota Heart Survey Am. J. Epidemiol. 156 2002 929 935
7. K.M. Flegal, M.D. Carroll, C.L. Ogden, and C.L. Johnson Prevalence and trends in obesity amoung US adults, 1999-2000 JAMA 288 1998 1723 1727
8. J.L. Dixon, and H.N. Ginsberg Hepatic synthesis of lipoproteins and apolipoproteins Semin Liver Dis. 12 1992 364 372
9. M.C. Jong, M.H. Hofker, and L.M. Havekes Role of apoCs in lipoprotein metabolism. Functional differences between apoC1, apoC2 and apoC3 Arterioscler. Thromb Vasc. Biol. 19 1999 472 484
10. H.M. Hodis, and W.J. Mack Triglyceride-rich lipoproteins and the progression of coronary artery disease Curr. Opin. Lipidiol. 6 1995 209 214
11. K. Olin-Lewis, R.M. Krauss, M. La Belle, P.J. Blanche, P.H.R. Barrett, and T.N. Wight Apo C-III content of apoB-containing lipoproteins is associated with binding to the vascular proteoglycan biglycan J. Lipid. Res. 43 2002 1969 1977
12. P. Wang-Iverson, H.N. Ginsberg, L.A. Peteanu, N.A. Le, and W.V. Brown Apo E-mediated uptake and degradation of very low density lipoproteins by human monocyte macrophages: a saturable pathway distinct from the LDL receptor Biochem. Biophys. Res. Commun. 126 1985 578 586
13. Z.R. Cordero-MacIntyre, T.G. Lohman, J. Rosen, W. Peters, R.C. Espana, and B. Dickinson Weight loss is correlated with an improved lipoprotein profile in obese postmenopausal women J. Am. Coll. Nutr. 19 2000 275 284
14. C.C. Allain, L.C. Poon, C.S. Chan, W. Richard, and P.C. Fu Enzymatic determination of total serum cholesterol Clin. Chem. 20 1974 470 475
15. +2 precipitation procedure for quantitation of high-density- lipoprotein cholesterol Clin. Chem. 28 1982 1379 1388
16. W.T. Friedewald, R.I. Levy, and D.S. Fredirckson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin. Chem. 18 1978 499 502
17. T. Carr, C.J. Anderssen, and L.L. Rudel Enzymatic determination of triglycerides, free cholesterol, and total cholesterol in tissue lipid extracts Clin. Biochem. 26 1993 39 42
18. N. Rifai, and M.E. King Immunoturbidimetric assays of apolipoproteins A-I, A-II and B in serum Clin. Chem. 32 1986 957 960
19. A. Frendenrich, L.M. Giroux, M. Tremblay, L. Krimbou, J. Davingnon, and J.S. Cohn Plasma lipoprotein distribution of apo C-III in normolipidemic and triglyceridemic subjects: comparison of the apo C-III to apo E ratio in different lipoprotein fractions J. Lipid. Res. 38 1997 1421 1432
20. J.S. Cohn, M. Tremblay, M. Amiot, D. Bouthillier, M. Roy, and J. Genest Jr Plasma concentration of apolipoprotein E in intermediate-size remnant-like lipoproteins in normolipidemic and hyperlipidemic subjects Arterioscler. Thromb. Vasc. Biol. 16 1996 149 159
21. G.L. Vega, M.A. Denke, and S.M. Grundy Metabolic basis of primary hypercholesterolemia Circulation 84 1991 118 128
22. F. Pont, L. Duvillard, E. Florentin, P. Gambert, and B. Verges Early kinetic abnormalities of apo B-containing lipoproteins in insulin-resistant women with abdominal obesity Arterioscler. Thromb. Vasc. Biol. 22 2002 1726 1732
23. N.S. Shachter Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism Curr. Opin. Lipidol. 12 2001 297 304
24. G. Camejo The interaction of lipids and lipoproteins with the intercellular matrix of arterial tissue: its possible role in atherogenesis Adv. Lipid. Res. 19 1982 1 53
25. R.W. Mahley Apolipoprotein E: cholesterol transport protein with expending role in cell biology Science 240 1988 622 630
26. Y. Huang, X.Q. Liu, S.C. Rall, J.M. Taylor, A. von Eckardstein, and G. Assman Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia J. Biol. Chem. 273 1998 26388 26393